Sort
53,477 grants matching “addiction”
Incentivized Collaborative Care to Desseminate Contingency Management
$819,079David R Gastfriend · Dynamicare Health, Inc. · R44 · FY2023 · DA
Cherokee Nation Prevention Trial: Interactive Effects of Environment & SBIRT
$818,914Kelli Ann Komro · University Of Florida · R01 · FY2011 · AA
NIDA Clinical Trials Network: Greater New York Node
$818,688John P Rotrosen · New York University School Of Medicine · UG1 · FY2016 · DA
Medication Development for Protracted Abstinence in Alcoholism
$818,653Scripps Research Institute · R01 · FY2005 · AA
Development and Validation of a Stimulant Use Disorder Severity Scale
$818,486Brian D. Kiluk · Yale University · UG3 · FY2025 · DA
Development of Angiotensin AT2 inhibitors for neuropathic pain relief
$818,360Vsevolod Katritch · University Of Southern California · UG3 · FY2025 · NS
The Neural Underpinnings of Depression and Cannabis Use in Young PLWH
$818,232Vilma Gabbay · Albert Einstein College Of Medicine · R01 · FY2021 · DA
The Neural Underpinnings of Depression and Cannabis Use in Young PLWH
$818,231Vilma Gabbay · Albert Einstein College Of Medicine · R01 · FY2022 · DA
NCI Program for Natural Products Discovery - Cures
$818,176Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Mindful Moms in Recovery: Yoga-based mindfulness relapse prevention for pregnant women with opioid disorder
$818,003Sarah E Lord · Dartmouth College · R33 · FY2019 · AT
Incentives for Suppression of HIV-1 RNA in People Living with HIV
$817,836Kenneth Silverman · Johns Hopkins University · R01 · FY2015 · AI
Intensive Models of HCV Care for Injection Drug Users
$817,702Alain Litwin · Albert Einstein College Of Medicine · R01 · FY2012 · DA
Project 1: Toxicity testing of New & Manipulated Tobacco Products p139-181
$817,527Pamela I Clark · Univ Of Maryland, College Park · P50 · FY2015 · CA
Establishment and Characterization of Novel Mutant Mouse Models for the Addiction Research Community
$817,399Vivek Kumar · Jackson Laboratory · U01 · FY2022 · DA
Interdepartmental Neuroscience Center
$817,302Xandra Owens Breakefield · Massachusetts General Hospital · P30 · FY2012 · NS
VACCINATION FOR TREATMENT OF NICTOTINE DEPENDENCE
$817,093Nabi Biopharmaceuticals · U19 · FY2001 · DA
Novel PET imaging agents for understanding glutamine addiction in cancer
$816,810Hank F Kung · University Of Pennsylvania · R01 · FY2011 · CA
Center for Metabolic Research on HIV and Drug Use
$816,761Sherwood L Gorbach · Tufts University Boston · P30 · FY2011 · DA
Development & Manufacture of Pharmaceutical Products for Addiction Treatment
$816,752Ram B. Murty · Murty Pharmaceuticals, Inc. · N01 · FY2010 · DA
Project 3: Adolescent smoking: Vulnerability to Tobacco Use and Market p265-296
$816,109Jonathan M. Samet · University Of Southern California · P50 · FY2013 · CA
Cognitive Reappraisal for Mitigating Incubation of Cocaine Cue-Reactivity
$815,875Muhammad Adeel Parvaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DA
Maternal Brain and Behavioral Responses to Infant Cues in Cocaine Exposed Mothers
$815,666Lane Strathearn · Baylor College Of Medicine · R01 · FY2010 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$815,543Philip Todd Korthuis · Oregon Health & Science University · UG1 · FY2025 · DA
Novel PET imaging agents for understanding glutamine addiction in cancer
$815,482Hank F Kung · University Of Pennsylvania · R01 · FY2012 · CA
Clinical Laboratory Core
$815,391Jennifer W Tidey · Brown University · P20 · FY2020 · GM